US Patent 7176210 Cannabinoid receptor ligands and uses thereof
Patent 7176210 was granted and assigned to Pfizer on February, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
David A. Griffith0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+209 characters)
Article
Patent abstract
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07176210 Cannabinoid receptor ligands and uses thereof US Patent 7176210 Cannabinoid receptor ligands and uses thereof
Infobox
Patent Number
071762100
Patent Number
71762100
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071762100
Date of Patent
February 13, 2007
0Patent Application Number
107629590
Date Filed
January 21, 2004
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07176210 Cannabinoid receptor ligands and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07176210
Date of patent
February 13, 2007
Patent application number
10762959
Date Filed
January 21, 2004
Patent primary examiner
Find more entities like US Patent 7176210 Cannabinoid receptor ligands and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
